Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-002618

President sold 30,000 shares at an average $56.58 ($1,697,386)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-04 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-04 Sale : show line 2 in the form −6,371 $56.05 $357,095 8,629 D
2021-01-04 Sale : show line 3 in the form −3,169 $57.52 $182,281 5,460 D
2021-01-04 Sale : show line 4 in the form −4,751 $58.09 $275,986 709 D
2021-01-04 Sale : show line 5 in the form −709 $59.40 $42,115 0 D
2021-01-05 Exercise or conversion : show line 6 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-05 Sale : show line 7 in the form −14,637 $55.98 $819,379 363 D
2021-01-05 Sale : show line 8 in the form −363 $56.56 $20,531 0 D
Open-market sales · 30,000 sh · avg $56.58 · $1,697,386

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-04 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −15,000 365,000 D
2021-01-05 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −15,000 350,000 D
Loading xslF345X03/doc4.xml…